Hqp-1351 Free Base Uses, Dosage, Side Effects and more
Hqp-1351 Free Base is under investigation in clinical trial NCT03883100 (A Pivotal Study of Hqp-1351 Free Base in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation).
| Trade Name | Hqp-1351 Free Base |
| Generic | HQP1351 |
| HQP1351 Other Names | Hqp-1351 free base, Hqp1351 free base, Olverembatinib |
| Type | |
| Formula | C29H27F3N6O |
| Weight | Average: 532.571 Monoisotopic: 532.219844002 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
